4.3 Review

Macrophages: important players in primary Sjogren's syndrome?

Journal

EXPERT REVIEW OF CLINICAL IMMUNOLOGY
Volume 10, Issue 4, Pages 513-520

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1586/1744666X.2014.900441

Keywords

IFN-gamma; primary Sjogren's syndrome; IL-1 beta; squamous metaplasia; macrophages; dry eye disease; clodronate liposome; IL-1 receptor antagonist; keratoconjunctivitis sicca

Categories

Ask authors/readers for more resources

Primary Sjogren's syndrome (pSS) is a chronic autoimmune disorder characterized by immune-mediated destruction of the salivary and lacrimal glands with unknown etiology. Due to recent research utilizing human subjects as well as laboratory animal models, our understanding of the pathophysiological and immunological mechanisms of pSS has made great strides. As a consequence, targeted, immune-based therapies are gaining increased attention as the ideal way to conquer autoimmune diseases like pSS. Currently, however, there is no effective treatment to target specific immunological events or effector immune cells in the pathogenesis of pSS (discussed in other reviews of the current issue). Here, we summarize our current understanding and knowledge of the roles of monocytes/macrophages in the pathogenesis of pSS. Human studies, especially utilizing salivary gland biopsies, demonstrate the infiltration of macrophages and its correlation with disease severity. Moreover, animal model studies have shown the functional involvement of macrophages in promoting the ocular component of pSS.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available